πŸ‡ΊπŸ‡Έ FDA
Patent

US 9120776

Condensed heterocyclic compound

granted A61KA61K31/403A61K31/404

Quick answer

US patent 9120776 (Condensed heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/403, A61K31/404, A61P, A61P1/04